Publicaciones en colaboración con investigadores/as de Universidad de Murcia (19)

2024

  1. Predictors of unsustained measurable residual disease negativity in transplant-eligible patients with multiple myeloma

    Blood, Vol. 143, Núm. 7, pp. 597-603

2023

  1. A Human Hereditary Cardiomyopathy Shares a Genetic Substrate With Bicuspid Aortic Valve

    Circulation, Vol. 147, Núm. 1, pp. 47-65

  2. Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance-Like Phenotype in Patients With Monoclonal Gammopathies

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, Núm. 16, pp. 3019-3031

  3. Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance

    Nature Communications, Vol. 14, Núm. 1

  4. NLRP3 inflammasome activation and symptom burden in KRAS-mutated CMML patients is reverted by IL-1 blocking therapy

    Cell Reports Medicine, Vol. 4, Núm. 12

2022

  1. Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma

    Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 28, Núm. 21, pp. 4771-4781

  2. Molecular Dissection of Structural Variations Involved in Antithrombin Deficiency

    Journal of Molecular Diagnostics, Vol. 24, Núm. 5, pp. 462-475

  3. Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT)

    European heart journal. Cardiovascular pharmacotherapy, Vol. 8, Núm. 3, pp. 291-301

2020

  1. RNA-binding protein Rnc1 regulates cell length at division and acute stress response in fission yeast through negative feedback modulation of the stress-activated mitogen-activated protein kinase pathway

    mBio, Vol. 11, Núm. 1

2019

  1. Molecular Diagnosis of Inherited Coagulation and Bleeding Disorders

    Seminars in Thrombosis and Hemostasis, Vol. 45, Núm. 7, pp. 695-707

  2. Phosphatidylinositol Monophosphates Regulate Optimal Vav1 Signaling Output

    Cells, Vol. 8, Núm. 12

2017

  1. Eficacia de la terapia de reminiscencia grupal en personas con demencia. Revisión sistemática y metaanálisis

    Revista de Neurologia, Vol. 65, Núm. 10, pp. 447-456

2016

  1. Uniparental disomy causes deficiencies of vitamin K-dependent proteins

    Journal of Thrombosis and Haemostasis, Vol. 14, Núm. 12, pp. 2410-2418

2013

  1. The dioxin receptor has tumor suppressor activity in melanoma growth and metastasis

    Carcinogenesis, Vol. 34, Núm. 12, pp. 2683-2693

2008

  1. Inhibition of proteasome by bortezomib causes intracellular aggregation of hepatic serpins and increases the latent circulating form of antithrombin

    Laboratory Investigation, Vol. 88, Núm. 3, pp. 306-317

2007

  1. Antithrombin Cambridge II (A384S): An underestimated genetic risk factor for venous thrombosis

    Blood, Vol. 109, Núm. 10, pp. 4258-4263

2005

  1. Evidence of involvement of the nNOS and the κ-opioid receptor in the same intracellular network of the rat periaqueductal gray that controls morphine tolerance and dependence

    Molecular Brain Research, Vol. 137, Núm. 1-2, pp. 166-173

  2. Role of vascular nitric oxide in experimental liver cirrhosis

    Current Vascular Pharmacology, Vol. 3, Núm. 1, pp. 81-85

2000

  1. Recombinant C1b domain of PKCδ triggers meiotic maturation upon microinjection in Xenopus laevis oocytes

    FEBS Letters, Vol. 483, Núm. 1, pp. 27-32